Source: Eur Respir J 2002; 19: 872-878
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Acuna A.A., Gabrijelcic J., Uribe E.M., Rabinovich R., Roca J., Barbera J.A., Chung K.F., Rodriguez-Roisin R.. Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma. Eur Respir J 2002; 19: 872-878

Member's Comments

No comment yet.

Related content which might interest you: Formoterol protects against platelet-activating factor-induced effects in asthma Source: Eur Respir J 2004; 23: 71-75 Year: 2004 Effects of salmeterol/fluticasone propionate (SFC) on airway inflammation in induced sputum in COPD Source: Annual Congress 2005 - Effects of anti-inflammatory drugs on COPD Year: 2005 Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma Source: Eur Respir J 2006; 27: 172-187 Year: 2006 Inhaled corticosteroids and growth of airway function in asthmatic children Source: Eur Respir J 2004; 23: 861-868 Year: 2004 Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma Source: Eur Respir J 2002; 20: 1080-1087 Year: 2002 Effects of roflumilast on exhaled NO, airway hyperresponsiveness, and inflammatory markers in patients with asthma Source: Eur Respir J 2006; 28: Suppl. 50, 670s Year: 2006 Montelukast versus fluticasone: effects on lung function, airway responsiveness and inflammation in moderate asthma Source: Eur Respir J 2002; 20: 853-858 Year: 2002 Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment Source: Eur Respir J 2006; 27: 964-971 Year: 2006 Benralizumab attenuates airway eosinophilopoietic processes in prednisone-dependent asthma Source: International Congress 2017 – Monitoring novel biomarkers in asthma Year: 2017 Neutrophil airway influx by platelet-activating factor in asthma: role of adhesion molecules and LTB4 expression Source: Eur Respir J 2003; 22: 290-297 Year: 2003 Pulmonary gas exchange responses to histamine and methacholine challenges in mild asthma Source: Eur Respir J 2001; 17: 609-614 Year: 2001 Effects of fluticasone and ciclesonide on pulmonary function and airway inflammation in stable mild asthmatics Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009 Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma Source: Eur Respir J 2001; 18: 444-450 Year: 2001 Evaluation of the effect of inhaled ciclesonide on inflammatory and allergic markers and pulmonary function in bronchial asthma Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy Year: 2008 Montelukast inhibits bronchoconstriction and gas exchange defects induced by leukotriene D4 challenge in asthma Source: Eur Respir J 2002; 20: Suppl. 38, 308s Year: 2002 Salbutamol but not ipratropium fully abolish leukotriene D4-induced gas exchange abnormalities and induced sputum eosinophilia in asthma Source: Eur Respir J 2003; 22: Suppl. 45, 412s Year: 2003 Influence of inhaled corticosteroids on airway epithelial cell mediator release in wheezing children Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008 Effect of the addition of montelukast on airway inflammation and remodeling in symptomatic asthma Source: International Congress 2017 – Asthma: mechanisms and treatment Year: 2017 Effects of N-acetylcysteine on airway inflammation, airway hyperresponsiveness and abnormal lung function in chronic ozone-induced COPD model Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 Inhaled doxycycline reduces allergen-induced airway inflammation, hyperresponsiveness and remodelling in mice Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma Year: 2005